Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs SLNB for Non-Intubated Laryngeal Surgery
NCT05581485Completed
- Sponsor
- Kaohsiung Veterans General Hospital
- Start
- Nov 2022
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dexmedetomidine in Laryngeal Diseases (2 arms), sponsored by Kaohsiung Veterans General Hospital. Primary endpoint: Arterial Partial Pressure of Carbon Dioxide. Started Nov 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Laryngeal Diseases
Beyond the preview
Go deeper on NCT05581485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05581485.